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Tuberculosis remains one of the deadliest 
infectious diseases in Vietnam. Its occurrence is 
exacerbated by erratic treatment, in particular by 
taking medication only sporadically or if patients 
discontinue the medication in an early stage. Previous 
approaches to support treatment adherence focus on 
monitoring (e.g., tele-observation) or external 
stimulation (e.g., rewards). These approaches, 
however, have not yet shown the desired effects. We 
assert that this is because current approaches focus on 
combatting the outcome, i.e., erratic treatment, 
instead of tackling the reasons for treatment non-
compliance. Notably, the latter is heavily related to the 
stigmatization of TB patients and, especially, self-
stigmatization. Using a design science research 
approach, this paper proposes a research plan for 
developing a gamified information system that aims at 
reducing patients self-stigmatization, by providing 
features that support TB patients community building 
as well as TB patients empowerment.    
1. Introduction  
Being one of the top ten causes of death globally 
as well as the leading cause of death from a single 
infectious agent ranking even above HIV, tuberculosis 
(TB) remains an urgent public health threat [1,2]. 
While a timely diagnosis and treatment with first-line 
antibiotics for six months can cure most patients and 
prevents onward transmission, erratic treatment 
adherence leads to the continued spread of the 
infection, disease chronicity, and especially the 
acquisition of multi-drug resistant forms of TB (MDR-
TB) [3]. In a recent report, the World Health 
Organization (WHO) draws attention to about half a 
million new cases of MDR-TB globally in 2018, 
whose treatment with second-line antibiotics is 
significantly longer (from 9 up to 20 months) and more 
expensive (≥ U.S.$ 1,000 per person) than the 
treatment of non-resistant forms of the infection [4]. 
At the same time, the treatment success rate of MDR-
TB is only at 56% globally [1]. 
As MDR-TB provides a severe threat to the 
WHO's efforts aiming at containing TB infections, 
several studies focus on the circumstance of patients 
developing drug-resistant forms of TB. Qualitative 
studies suggest that interrupted treatment and missing 
drug doses is a significant risk factor for developing 
MDR-TB, whereas one crucial determinant of 
treatment non-compliance is TB patients' 
stigmatization [5,6]. 
 Stigma involves the exclusion, rejection, blame 
or devaluation resulting from experience or reasonable 
anticipation of an adverse social judgment [7], thereby 
being a social determinant that affects health outside 
of the ease with which an individual can access 
medical services [6]. Notably, there are several 
reported cases where TB stigma harmed treatment 
adherence and the regular intake of drug doses. For 
instance, TB stigma was the most common motivation 
cited by HIV-infected Tanzanian patients who did not 
complete isoniazid preventive therapy [8]. Also, TB 
stigma is associated with non-compliance among 
Pakistani TB patients on direct observatory therapy, 
i.e., a specific strategy of the WHO to improve 
adherence by requiring health workers, community 
volunteers, or family members to observe patients in 
being compliant with their prescribed medical 
treatment [6,9]. 
Given the stigmatization of TB patients and the 
associatively increased likelihood of developing 
MRD-TB through a discontinued use of medication, 
researchers aim at supporting treatment adherence 
using new information and communication 
technologies (ICTs), especially, by developing digital 
health services. Digital health services are seen as 
especially promising as they provide novel 
opportunities to combat TB. Thus us because, as 
global connectivity expands and modern ICTs become 
more widely available and affordable, digital health 





services are destined to become increasingly present 
ans supportive in the daily life of TB patients [2,3].  
So far, however, studies investigating the 
effectiveness of digital or mobile health services on 
patients health and treatment adherence attested only 
limited impact. For instance, interactive SMS 
reminders [10], as well as direct video observation 
used to control drug intake, showed only limited 
effectiveness [11,12]. Researchers have shown that 
SMS reminders and direct video observation instead 
serve as a reminder for patients who have 
demonstrated prior good adherence, but that they are 
not effective if in the case of patients making an active 
effort to avoid therapy, e.g., pretending to swallow. 
This paper argues that the reasons for the current 
lack of efficiency of digital health services aiming at 
fostering TB treatment adherence might be two folded. 
First, current health services focus on the outcome and 
control aspects of TB treatment adherence rather than 
on the causes of treatment non-compliance, which is 
frequently observed to be TB stigma as well as 
consequential effects, such as social isolation, the loss 
of job and working hours, and food insecurity. Second, 
by focusing on the outcome instead of the causes of 
treatment non-compliance, patients are exposed to 
high external pressure, eventually leading to a lower 
individual sense of self-efficacy and self-control 
[3,13,14].  
Therefore, we propose a digital health service that 
fosters personal responsibility for one’s own health on 
the one side, while helping patients to cope with TB 
stigma on the other side. We intend to accomplish this 
by assisting patients to build communities among 
infected, thereby integrating gamified design elements 
that foster personal engagement, a sense of belonging, 
and digital interaction in the course of the TB 
treatment. Specifically, we focus on the aspect of 
community building, since it has already been shown 
to be an effective tool against the spread of TB and 
HIV/AIDS in Africa, achieved through the 
empowerment of patients and the increase of self-
responsibility [6].  
Putting these insights together, this paper is 
dedicated to describe a comprehensive research plan 
to design and develop a gamified TB treatment 
adherence system that not only tackles the issue of 
treatment non-compliance but also fosters patients' 
engagement in TB therapy. Drawing on cognitive 
evaluation theory, we argue that the current health 
services are rarely sufficient to keep patients 
engagement in their long-term treatment plan, as they 
are solely exposed to extrinsic motivation (i.e., the use 
of controls or reward programs). By designing a 
gamified system, however, we focus on fostering 
intrinsic motivation, which is consistently more 
predictive of human behavior than extrinsic 
motivation [15,16]. 
Although often reduced to joy alone, intrinsic 
motivation involves other factors such as the need for 
competence (i.e., self-esteem) and autonomy (i.e., 
personal control), whose activation enables patients to 
take more responsibility for their health [17]. Aimed 
at triggering intrinsic motivation, we implement game 
design elements (e.g., collecting badges or reward 
points, visualization of achievements, social 
discovery, or quests) that foster community building 
and exchange between those affected. As a result, we 
expect patients to empower themselves and others, 
which actively reduces the negative effects of TB 
stigmatization.  
The remainder of this paper is structured as 
follows: The next section briefly describes the 
framework that guides our approach in designing a 
gamified system for TB treatment adherence. Notably, 
we elaborate on the elements of the framework, 
including our target system, i.e., a district in Ho-Chi-
Minh city in Vietnam, which is known to be a high-
burden MDR-TB country [1]. In the following section, 
we propose research steps needed to be conducted to 
design a gamified system for TB drug adherence as 
outlined above. As we apply design science research, 
we further explain and specify the assessment criteria 
for the system and eventually provide a conclusion and 
outlook.  
2. Gamified System Design Framework 
Gamification is defined as the incorporation of 
game design elements into a target system [18]. While 
often confused with full-fledged games, gamification 
merely adds a layer to the real world, without 
scarifying real-world functionalities. The design of a 
gamified system, thus, is imbued with high complexity 
since there is the need for taking into account both real 
words and game functionalities. Given this 
complexity, [18] developed a framework that guides 
researchers in their attempt to design gamified 
systems, as depicted in Figure 1. Notably, the 
framework is divided into four building blocks, which 
we describe briefly in the following.  
2.1 Gamified System 
The first building block is the gamified system, 
which, consisting of both gamification objects and 
gamification mechanics. Gamification objects thereby 
describe the basic building blocks of a gamified 
system, including items, characters, or visual assets, 
which either serve to create sensory experiences or 
provide functionalities. Gamification mechanisms 
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refer to the rules that govern the interaction between 
the user and the game objects, e.g., rules concerning 
how many points users get for a specific activity in a 
reward-based game [18]. Notably, several possible 
gamification mechanics mainly depend on the target 
systems' characteristics, meaning that design elements 
need to be congruent with the targeted users, tasks, and 
the technology [18]. 
2.2 User-System Interaction 
Gamification mechanics plus actions taken by the 
user result in user-system interaction, which is the 
second building block of the gamified system design 
framework. While the importance of user-system 
interaction is often underestimated in design science 
research approaches (as they are typically solution-
oriented) [19], in gamified systems, user-system 
interaction is of utmost importance and includes 
system-user communication as well as communication 
with other users [18]. Eventually, setting up the user-
system communication significantly influences the 
quality of the communication, e.g., how feedback is 
present to users and determines its overall acceptance 
among users.  
2.3 Gamification Design Principles 
Gamification design principles or higher-level 
design principles are formulas or rules for designers. 
For instance, design principles can be expressed in 
how users onboard to the game, by keeping outcomes 
uncertain or providing frequent rewards and 
immediate feedback supporting different user styles 
[18]. Examples of gamification design principles 
include the use of timely feedback, the ability to set 
personalized goals and messages as well as social 
supports, e.g., to give other users positive 
encouragement [18].  
Gamified principles, as well as all other building 
blocks of the gamified system, however, need to be 
carefully planned, reviewed constantly, and be 
discarded if necessary. This is because gamified 
design systems often do not work as intended as 
divergent dynamics emerge while in use. Particularly, 
this means that there is a paucity of practice-based 
wisdom that can guide and promise a successful 
development and implementation of our intended  
 
gamified system. Consequently, when elaborating on 
our intended outcome, i.e., meaningful engagement, 
we need to obey that designing for this outcome is 
probably hard as it emerges over time and patients' 
interest to work and engage within the system [18].   
2.4 Meaningful Engagement 
Eventually, meaningful engagement represents 
the overarching goal of a gamified system. In 
particular, [18] describe meaningful engagement to be 
consisting of two building blocks, i.e., instrumental 
and experimental outcomes. While instrumental 
outcomes are purpose orientated, i.e., the increase of 
sales or inclines in the total number of users, 
experimental outcomes address the psychological state 
of a recipient's perception by, for example, creating 
positive feelings or emotions that lead to an improved 
engagement with the gamified system. Experimental 
outcomes should, thereby, not be understood as a mere 
additional benefit in the sense of positive side effects, 
but as equally important as the instrumental outcomes 
[18]. Notably, [18] recommend the identification of 
desired experimental outcomes before the gamified 
system is designed in order to support the creation of 
instrumental outcomes. 
Figure 2. Framework to design a gamified system Figure 1. Framework t  i  a gamified system 
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3. Research Plan: Toward Designing a 
Gamified System for TB Drug Adherence 
We follow a design science research (DSR) 
approach [19] to develop and design a gamified drug 
adherence system that incorporates and obeys the 
building blocks of the above-presented framework 
[18]. Thereby, we build upon accumulated design 
knowledge in the solution space, i.e., we use the 
framework that was built to solve related problems 
(i.e., its usage to design gamified systems) and transfer 
this knowledge to the contextual problem space of TB 
stigmata and its relationship with TB treatment 
adherence in urban Vietnam [20].  
We strive for a mainly solution-oriented DSR 
project by going through the six main phases of the 
DSR process, i.e., problem identification and 
motivation, definition of objects, design and 
development, demonstration, evaluation, and 
communication [19,21]. To achieve patients' 
engagement in community building and to foster TB 
patients' empowerment, we use the described 
framework [18], concerned with the design of 
gamified systems for guidance, and as a knowledge 
base to develop and design the treatment adherence 
system.  
We start describing our approach by opening up 
the problem space and describing the target system in 
the following.  
Problem space and target system: The DSR 
approach, as well as the framework, require – in a first 
step – to fully grasp the problem space residing within 
the target system. We aim at implementing a gamified 
TB adherence system in a district of Ho-Chi-Minh 
City, Vietnam, which is known to be profoundly 
affected by TB [1]. Vietnam is a middle-income 
country in Southeast Asia, with a TB incidence of 182 
per 100,000 population in 2018 [1]. While the country 
makes ongoing progress in reducing the overall TB 
burden by approximately 3% per year over the past ten 
years through a range of interventions (e.g., household 
contact investigation, TB preventive treatment, new 
TB diagnostics, active case finding), the WHO 
classifies Vietnam as a high TB and, especially, high 
MDR-TB burden country [4]. Tuberculosis control is 
centrally administered by the National TB Program 
(NTP), and first-line medications are dispensed free-
of-charge, mostn commonly once a week by health 
workers at district clinics or commune health posts 
[22]. Despite the free dispense of antibiotics and 
support from various NGOs, TB remains one of the 
most severe forms of infectious diseases in Vietnam, 
which is, among others, because of the still 
predominant stigmatization of TB patients, whereby 
stigmatization is a social determinant of health [6]. In 
particular, it has been shown that the prevalence of the 
TB in Vietnam is even mainly due to social 
determinants and indirect costs of the disease, 
including, among others, stigmatization, loss of 
employment, discrimination, and additional costs due 
to extra travel or food supplementary costs [6].  
Design objectives: Following the DSR 
methodology, we aim to define objectives, i.e., what a 
(better) artifact has to accomplish, in a second step 
[19]. We, thereby, target each of the building blocks 
of the gamified design framework subsequently, 
starting with the outcome, i.e., the instrumental and 
experimental outcome which comprise meaningful 
engagement, as proposed by [18]. Table 1 summarizes 
the key guiding research questions, the proposed 
approach, as well as the objective for each of the 
framework's building blocks. Within the framework of 
the design project, we will work through these steps 
one after the other and divide them into individual 
research projects.  
Demonstration: DSR research requires the 
demonstration of the artifact, e.g., the prototype 
designed. While this is out of the scope for this paper, 
it is intended to be addressed in future works after all 
the design-specific characteristics of the system have 
been specified. Notably, this also holds for the 
communication of results, being the final step of the 
DSR methodology [19]








What is the patients' desired 
instrumental and experimental 
outcome when using the gamified 
system? 
• Identification of issues and factors 
that prevent the continuous intake of 
TB medication using semi-structured 
interviews [23] 
Create a system design that 
incorporates functionalities 
required by TB patient, which 
enhance the feeling of control 





What are the concrete game 
objects and mechanics that 
promote meaningful engagement 
• Literature overview of already 
applied gamified systems, the 
context, and their effectiveness.  
Identification and 
implementation of concrete 
design elements that promote 
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• Creation of an evaluation matrix that 
helps to classify the usefulness of 
gamified elements from a 'user's 
perspective or rating [24] 
the instrumental and 
experimental outcomes from 




How can we translate the relation 
of patients' needs and game 
objects/mechanics into higher-
order principles, i.e., core 
properties of the gamified 
system? 
• Literature review on gamification 
principles (e.g., autonomy, local 
interactivity, rules of engagement, 
communication) and their 
effectiveness [25] 
• Mapping of identified mechanism to 
the target system and game objects/ 
mechanics [26]  
Identification and 
actualization of affordances of 
the gamified system by 
design, i.e., providing general 
action possibilities opened up 




What are the desired 
technological and functional 
affordances of the gamified drug 
adherence system? 
How can we design a gamified 
system such that affordances are 
immediately perceptible by users? 
• User observation of patients using a 
prototype of the gamified system 
[27] 
• Adaption of the prototype to design 
for affordance actualization [28] 
Identification and 
actualization of affordances of 
the gamified system by 
design, i.e., providing general 
action possibilities opened up 
by the system to the patient. 
While there is no prototype readily available now, 
we want to use this paper to demonstrate the expected 
and intended impacts of the system on the current state 
and relationship between the government, NGOs, 
public and private healthcare facilities, and patients. 
Figure 2 shows these relationships and associated 
responsibilities characterizing the state of control of 
and care for TB and TB patients in Vietnam.  
Following [8] and [13], the current TB control and 
care system creates barriers to patients treatment 
success and adherence that are, among others, caused 
by the distance of patient's houses to clinics they have 
to visit in order to receive their treatment as well as the 
time and costs for traveling to private or public clinics.  
 
 
Moreover, patients recorded that they often forgot 
or intentionally omitted scheduled appointments due 
to expected stigmatization, meaning that both practical 
and psychosocial barriers to attend and to adhere to  
treatments are present in the current TB control and 
care system [29]. 
While it would be naïve to assume that scholarly 
recommendations and proposed interventions aimed at 
improving practical aspects and the functioning of the 
TB control and care system, are capable of sustainably 
changing the TB control and care system, instead, we 
propose evoluationary rather than disruptive measures 
to improve TB control and care in Vietnam. Notably, 
we want to demonstrate how the envisaged gamified 
system is likely to be integrated into the existing 
system thereby  expected to decrease psychosocial 
barriers for patients. Figure 3 exemplary depicts the 
integration of the gamified system in the current TB 
control and care system. With the 
introduction of the envisaged gamified 
system, we intend to stimulate patients' 
engagement. However, we also expect 
several cross effects to emerge that enhance 
and make the existing TB control and care 
system more efficient. Notably, we expect 
distinguishing impacts of the gamified system 
to unfold on three levels.  Thereby, we expect 
distinguishing impacts of the gamified system 
to unfold on an administrational, 






Figure 2. Current TB control and care 
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First, the envisaged gamified systems is intended 
to increase patients' engagement in well as 
acountability for patients' own health. Thereby, we 
expect an impact on the patients' personal level, which 
we define as patients' level of engagement in their TB 
treatment, arising from the use of the system for 
achieving and mastering game elements and 
mechanisms. The gamified systems also enables 
patients to compare their achievements with the ones 
of others, cheer each other up, as well as to get in touch 
with other patients. These features are enabled by the 
gamified systems' core functionalities, as summarized 
in the figure.  
Second, by using the system and engaging in 
gamified elements, health care service providers might 
receive insights into patients' overall health education, 
knowledge on TB and its dissemination. Vice versa, 
health care service providers are able to upload 
educational health information on the system, as well 
as potentially creating gamified challenges on their 
own by which means they were able to obtain further 
patient-related user data, enabling the analysis and 
evaluation of a patients individual  health status. 
Reminder functions, e.g., for appointments or drug 
intake, can be easily integrated into the system through 
the health service provider, which positively affects 
the administrational level of the TB control and care 
system. We define impacts of the administrational 
level as the extent of administrational ease that is 
achieved by the voluntary completion of playful tasks 
by patients and the release of data, which enables 
appointment reminders and other automated 
functionalities. 
Eventually, on an informational level, the 
gamified system serves as a centralized database that 
captures educational health information, patients' 
health status as well as additional information, such as 
weight and age, given the prerequisite that patients are 
willing to share these informations. We define the 
impact on the informational level as the degree of 
integration and share-ability of information through  
the digital storage of health-related data via the 
gamified system. 
Evaluation: For the evaluation of the envisaged 
gamified TB drug adherence systems, we will assess 
the following evaluation criteria, i.e., feasibility, 
usability, and acceptability. While we will attach great 
importance to the rigor of the research projects in the 
concrete development of the prototype, these criteria 
are initially aimed to show the applicability of the  
gamified system, since the overall success, i.e., the 
real-world impact, will be measured by this [30].  
Feasibility: Following [31], we define feasibility 
in the context of the gamified system as the extent to 
which we expect the implementation of the gamified 
system to be "easy" and convenient. Notably, we will 
account for how "easy" the system is integrable into 
the daily health routine of TB patients, as well as 
whether the system introduced inconvenience to 
patients or governmental or non-profit health care 
providers. Furthermore, we will assess whether the 
patients' mental load during thesuse of the system is 
manageable and whether if staff is needed to train 
patients to integrating the app into their daily life and 
health care routines [31].  
While these factors need to be tested, we expect 
mixed outcomes to result from the feasibility test. This 
is because Vietnam is among the countries with the 
highest rate of mobile phone ownership (131 mobile 
phone subscriptions per 100 inhabitants), and 
approximately 38,4 million are smartphone users [32]. 
Consequently, we expect that less effort will have to 
be invested into the integration of the system regarding 
patients' daily life if we provide mobile accessibility to 
the gamified system. At the same time, however, 
integration might be tricky if patients refuse to take 
their daily medication, either because they do not 
Figure 3. Expected impact of the gamified system on TB control and care 
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believe in the treatment or try to cover up the infection 
[6,33]. 
Usability: Usability is defined as the extent to 
which patients can adequately record and track data 
concerning their treatment adherence and whether or 
not the functions of the gamified systems enhance 
treatment compliance [31]. We, therefore, aim to test 
the effectiveness of the system in terms of both 
treatment compliance, as well as stigma reduction. 
While the first can be easily tracked using the system 
data, as well as health data, being easily integrated into 
the gamified system by providing interfaces to general 
health practitioners or hospitals treating TB patients, 
we will assess stigma reduction, using a stigma 
assessment scale [34,35]. In particular, we will 
develop and test a self-stigma scale to measure stigma 
patients suspected to have TB. In particular, we focus 
on self-stigmatization as we assume a lower level of 
self-stigmatization to be equal with patients' 
empowerment. This is because, while it is tough to 
change social believes about a disease within the 
society [6], our approach strives to changes the 
perception of stigmatization by patients through 
community-building and empowerment by the means 
of the gamified system.  
Acceptability: Acceptability of the gamified 
systems refers to question  whether or not the gamified 
system is likable by TB patients, including the 
interface and navigation features [31]. To ensure 
acceptability, we will conduct several iterations of pre-
prototype- and prototype acceptance testing [36]. 
Therefore, we are optimistic about designing a 
gamified TB treatment adherence system that is useful 
and acceptable to TB patients. However, there are 
overarching issues that affect usability and, especially, 
the acceptability of the gamified system, which require 
special investigation and testing.  
Overarching considerations: System and, 
especially, interface design are driven by cultural 
aspect [37]. Thus, we need to take into account that the 
initial design of the interface needs to be revised by 
several iterations until we reach a good culture-
technology fit. Otherwise, our system runs the risk of 
,despite providing suitable features, not being 
accepted and, consequently,  being effective [38]. 
Besides cultural aspects, differences in gender are also 
prevalent and should be taken into consideration. For 
instance, it has been shown that female TB patients 
have stronger fears about the consequences of their 
illness, including the misbelief that TB medication 
leads to sterility [39]. Therefore, we expect more 
resistance among female TB patients to test and use 
the gamified system, which we need to consider when 
designing the TB drug adherence system, e.g., by 
offering an incognito mode to test the gamified 
system. 
4. Conclusion and Outlook  
This paper provides initial insights into a 
comprehensive research project that aims to introduce 
a gamified system to support tuberculosis (TB) drug 
adherence by fostering engagement of patients in the 
course of their treatment through community-building 
and TB patients' empowerment. We propose to 
address the problem at the root by empowering TB 
patients through community building that is fostered 
by game design elements. In this research-in-progress 
paper, we focus on the objectives and evaluation 
criteria of our solution, which are subject to 
identification and investigation by empirical research. 
The relevance of this project is evident, when looking 
at the ever-present amount of multi-drug resistant 
cases of TB in Vietnam, that exist despite the public 
accessibility and free provision of TB tests and 
antibiotics through the Vietnamese government. 
Additionally, numerous non-governmental institutions  
advise and support patients with respect to the 
continuity of drug intake, thereby offering social care 
and health care. 
Moreover, while several solutions exist that 
already integrate new information and communication 
technologies in the treatment surveillance, they do not 
show the desired effectiveness. We submit that this is 
because they focus on the outcome, i.e., treatment non-
compliance, instead of focusing on the reasons for 
non-compliance. Among others, TB stigmatization is 
one such reason for treatment non-compliance.  
The proposed research project and approach to 
tackling TB treatment non-compliance in Vietnam, of 
course, needs to be viewed in light of the limitations. 
Primarily this means that we present a research project 
being in a very early stage of its development. 
However, given the social and practical relevance, as 
well as the theoretical foundation on which this 
proposal builds, we are convinced that this paper is of 
relevance for practitioners and researchers, 
encouraging discussions on the proposed solution, as 
well as on the use of gamified systems to address 
healthcare issues more generally.  
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